GSK-3β inhibitor 26
GSK-3β inhibitor 26 (Compound D14) is a GSK-3β inhibitor with an IC50 of 18.23 μM. GSK-3β inhibitor 26 can be used in the research of cancer, inflammation and neurodegenerative diseases[1].
Product Specifications
CAS Number
[70169-39-0]
UNSPSC
12352005
Target
GSK-3
Related Pathways
PI3K/Akt/mTOR; Stem Cell/Wnt
Field of Research
Cancer; Inflammation/Immunology; Neurological Disease
Smiles
O=C(C1=C(O)C=CC=C1)N/N=C2C(NC3=C\2C=CC=C3)=O
Molecular Formula
C15H11N3O3
Molecular Weight
281.27
References & Citations
[1]Dou X, et al. Discovery of new GSK-3β inhibitors through structure-based virtual screening. Bioorg Med Chem Lett. 2018 Jan 15;28 (2) :160-166.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
GSK-3β
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
125814-ML750 100 µL
DHFR (Dihydrofolate reductase) (MaxLight 750) discontinued
Sign In for Pricing
View Details 
GTR15178146 1 Vial
Lentiviral mouse Rab7 shRNA (UAS) - Lentiviral mouse Rab7 shRNA (UAS) (100)
Sign In for Pricing
View Details